Is a novel treatment breakthrough on the horizon?
Articles by Staff
Medical Decision Making and Coding
In my years of coding for rheumatology, I am often asked this type of question: “I have a patient who recently came in for a visit. She had two or three diagnoses, was placed on three or four different medications, and we ran one or two labs on her. Does this qualify for a level-four visit?”
I Am an Advocate
It was the best of times, it was the worst of times; it was the age of wisdom, it was the age of foolishness.” Cliché perhaps, but certainly fitting in describing the practice of rheumatology of late. We have been blessed with a widening array of therapies with which to treat rheumatologic illnesses. The advent of the biological era promises even greater potential for meaningful reductions in disability and death from these diseases.
An American in Paris
Visiting a historical city inspires reflections on the history and progress of rheumatology
A Workforce for the Future
The ACR is working hard to meet tomorrow’s needs
Rheum to Learn
The ARHP’s new NP/PA rheumatology training program will provide a boost to the workforce
Wegener’s Granulomatosis Treatment Today
WG has an evolving prognosis and treatment course
The Quest for Olympic Gold
What should physicians make of sick athletes’ success stories?
Get Involved!
A guide for applying to volunteer positions with the ACR
The Brain in Lupus
The Mary Kirkland Center lupus conference offers insight into cognitive aspects of SLE
- « Previous Page
- 1
- …
- 112
- 113
- 114
- 115
- 116
- …
- 150
- Next Page »